
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
FDA district offices may conduct site investigations to establish baseline information for sampling programs and tracking systems.
over 25 years ago
Emotion - The New Brand Integratorover 25 years ago
For Love of the Gameover 25 years ago
Field of Dreamsover 25 years ago
Workshop: Access Optionsover 25 years ago
Emotion - The New Brand Integratorover 25 years ago
Rx-to-OTC: Unwanted Attentionover 25 years ago
Emotion - Biotech Renaissance Manover 25 years ago
Relocation: Coming to Americaover 25 years ago
Stocks: Catching the Market Bluesover 25 years ago
Gathering Light





